Medicine and Dentistry
Human Immunodeficiency Virus
100%
Wart Virus
62%
Oropharyngeal Cancer
29%
Malignant Neoplasm
27%
Papillomavirus Infection
25%
Head and Neck Cancer
24%
Cohort Analysis
23%
Prevalence
21%
Human Papillomavirus Type 16
20%
Infection
15%
Neoplasm
12%
Men Who Have Sex with Men
11%
Squamous Cell
11%
Precancerous Condition
11%
Cohort Effect
11%
Anal Cancer
10%
Oropharynx Squamous Cell Carcinoma
10%
Cancer Cell
10%
Hazard Ratio
10%
Human Immunodeficiency Virus Infection
9%
Neck
9%
Cancer Risk
9%
Antiretroviral Therapy
9%
Odds Ratio
8%
Disease
7%
P16
7%
Head and Neck Squamous Cell Carcinoma
6%
Cervical Cancer
6%
Cytotechnology
6%
Cancer Screening
5%
Biological Marker
5%
Papanicolaou Stain
5%
Non-Hodgkin Lymphoma
5%
Cell Count
5%
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
41%
AIDS/HIV
32%
People Living with HIV (PLHIV)
32%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
31%
Confidence Interval
24%
Papillomavirus Infections
24%
HPV16
23%
Head-and-neck Cancer
22%
HIV Patients
19%
United States
18%
Multicenter AIDS Cohort Study
17%
Oral Human Papillomavirus
17%
Risk Factors
11%
HIV Status
11%
CD4 Count
11%
Antiretroviral Therapy
11%
HIV-positive
10%
Cervical Cancer
9%
Men Who Have Sex with Men
9%
Women's Interagency HIV Study
9%
HIV Infection
8%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
North America
8%
Head-and-neck
7%
HIV-negative
7%
Canada
6%
Adjusted Hazard Ratio
6%
Tumor
6%
Human Papillomavirus Vaccine
6%
Cancer Patients
6%
Living with
6%
Anal Cancer
6%
HPV Positive
6%
Epidemiology
6%
Squamous Cell Cancer
5%
Human Papillomavirus Types
5%
Odds Ratio
5%
Cancer Risk
5%
Pooled Analysis
5%
Oral HPV
5%
COVID-19
5%
